As well as being up-regulated in clinical and experimental atherosclerosis [48], CCL21 is also involved in neuroinflammation [49], [50], [51], suggesting how reductions in this chemokine secondary to intranasal E-selectin may also be beneficial in stroke. This evidence concerns the gene CCL21 and Stroke.